Erythromycin A 11,12-carbonates and method of use

Details Erythromycin A 11,12-carbonates and method of use Erythromycin A 11,12-carbonates and method of use

1985-11-12

1987-08-11

Brown, Johnnie R.

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Carbohydrate doai

536 72, A61K 3171, C07H 1708

Patent

active

046862072

ABSTRACT:
Disclosed herein are erythromycin derivatives of the formula ##STR1## wherein R.sub.1 is lower alkyl, aryl, alkene, aryl halide, alkylamino, hydroxyalkyl and furanyl, and pharmaceutically acceptable salts thereof. These compounds have improved oral absorption, reduced effects on gastrointestinal motility, increased acid stability and longer serum half-lives.

REFERENCES:
patent: 3842068 (1974-10-01), Tadanier et al.
patent: 4476298 (1984-10-01), Morimoto et al.

Affiliated with

Also associated with

Rating

Erythromycin A 11,12-carbonates and method of use does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Erythromycin A 11,12-carbonates and method of use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Erythromycin A 11,12-carbonates and method of use will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-402937